Skip to main content

Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).

Publication ,  Journal Article
Orgel, R; Wojdyla, D; Huberman, D; Halperin, JL; Breithardt, G; Singer, DE; Fox, KAA; Hankey, GJ; Mahaffey, KW; Jones, WS; Patel, MR
Published in: Circ Cardiovasc Qual Outcomes
May 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Cardiovasc Qual Outcomes

DOI

EISSN

1941-7705

Publication Date

May 2017

Volume

10

Issue

5

Location

United States

Related Subject Headings

  • Warfarin
  • Vitamin K
  • Stroke
  • Rivaroxaban
  • Randomized Controlled Trials as Topic
  • Peripheral Nervous System Diseases
  • Multicenter Studies as Topic
  • Humans
  • Factor Xa Inhibitors
  • Embolism
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Orgel, R., Wojdyla, D., Huberman, D., Halperin, J. L., Breithardt, G., Singer, D. E., … Patel, M. R. (2017). Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Circ Cardiovasc Qual Outcomes, 10(5). https://doi.org/10.1161/CIRCOUTCOMES.116.003520
Orgel, Ryan, Daniel Wojdyla, David Huberman, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Keith A. A. Fox, et al. “Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).Circ Cardiovasc Qual Outcomes 10, no. 5 (May 2017). https://doi.org/10.1161/CIRCOUTCOMES.116.003520.

Published In

Circ Cardiovasc Qual Outcomes

DOI

EISSN

1941-7705

Publication Date

May 2017

Volume

10

Issue

5

Location

United States

Related Subject Headings

  • Warfarin
  • Vitamin K
  • Stroke
  • Rivaroxaban
  • Randomized Controlled Trials as Topic
  • Peripheral Nervous System Diseases
  • Multicenter Studies as Topic
  • Humans
  • Factor Xa Inhibitors
  • Embolism